Martineau-Needham D, Lacey S
ILEP, London, United Kingdom.
World Health Stat Q. 1991;44(1):36-46.
The International Federation of Anti-leprosy Associations (ILEP) founded in 1966, consists of 22 autonomous nongovernmental organizations raising funds from the general public in the North for anti-leprosy work in the South. ILEP Member associations support over 800 field projects in 92 countries, in addition to over 130 research and other projects with a total annual expenditure of about US+ 60 million. 72% of the resources are spent on leprosy-control activities, 12% on training, 10% on research and 6% on socioeconomic activities. About 55% of resources are devoted to activities of national/regional leprosy programmes. ILEP-supported projects had detected over 100,000 patients in 1988. ILEP Member associations introduced WHO-recommended multidrug therapy (MDT) quite early, and the coverage for MDT in ILEP-supported projects has increased from 8% in 1984 to 35% in 1988 (271,000 patients in 1989 out of 769,000 on treatment). ILEP Member associations are currently supporting approaches towards integration of leprosy control with other services, urban leprosy programmes and social and physical rehabilitation. Thanks to their flexibility, their sense of innovation and their commitment to the worldwide anti-leprosy campaign, ILEP Members are well placed to meet the challenge of making MDT available to all leprosy patients by the year 2000.
国际抗麻风病协会联盟(ILEP)成立于1966年,由22个自主非政府组织组成,这些组织在北方从公众那里筹集资金,用于南方的抗麻风病工作。ILEP成员协会在92个国家支持800多个实地项目,此外还有130多个研究及其他项目,年总支出约6000万美元。72%的资源用于麻风病防治活动,12%用于培训,10%用于研究,6%用于社会经济活动。约55%的资源用于国家/地区麻风病项目的活动。1988年,ILEP支持的项目发现了超过10万名患者。ILEP成员协会很早就引入了世界卫生组织推荐的多药疗法(MDT),在ILEP支持的项目中,MDT的覆盖率已从1984年的8%增至1988年的35%(1989年,在接受治疗的76.9万名患者中有27.1万名接受了MDT治疗)。ILEP成员协会目前正在支持将麻风病防治与其他服务、城市麻风病项目以及社会和身体康复相结合的方法。由于其灵活性、创新意识以及对全球抗麻风病运动的奉献精神,ILEP成员协会完全有能力应对到2000年让所有麻风病患者都能获得MDT这一挑战。